Skip to content
Discover the latest in space technology, missions, and astr…

Social Media Influencers Fueling Unofficial Trade for Unapproved Weight-Loss Medication

An underground market for unlicensed weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Popularity Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share comparison images, injection guides and claims of rapid British shipping. Vendors market the substance there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

However, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering substances of unknown origin.

Several professionals stated the demand for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or prison.

Platform Reaction and Content Removal

Based on TikTok, the service has removed violative material and prohibited related hashtags and search suggestions. The organization said it was dedicated to maintaining the service secure and allocating resources in strengthening compliance measures.

Digital Trading Operations

Investigations also found groups with up to nine thousand participants selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with images of weight loss, glowing testimonials and detailed guides for preparing or injecting at home.

After minutes of entering one group, a seller shared WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Product Details and Pricing

Within these communities, messages show black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service said it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting materials they cannot confirm. Even if the research behind this drug is valid, these online products may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her staff has previously encountered patients injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject users to possibly significant health risks”.

Written by

Peter Ibarra

A passionate astrophysicist and science writer, sharing discoveries and inspiring the next generation of space explorers.

Orbit Ladder Max

Type to search articles.